AzTrials
AzTrials

Fall InjuryNCT05411536

Attentional Focus Instructions and Conscious Movement Processing in Older Adults

An observational study of Fall Injury and Walking, Difficulty, run by The Hong Kong Polytechnic University at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study aims to provide a novel scientific contribution through addressing critical knowledge gaps, examining the effects of attentional focus instructions on real-time (state) conscious movement processing propensity, gait parameters, and muscle efficiency in older adults in Hong Kong at risk of falling while… Read more about this study

Who is it for?
Ages 65 to 99 yearsHealthy volunteers can take part
Conditions the study is for
Fall Injury, Walking, Difficulty, Gait, Unsteady
What is being tested?
Walking trials
How many people
106 participants
Where
1 siteChina
Study dates
15 Jul 2022to 30 Jun 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 to 99 years
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Study population: Older adults (N = 106) will be recruited from different collaborating community elderly and rehabilitation centres in Hong Kong through convenience sampling. Potential participants will be screened for eligibility by the inclusion and exclusion criteria.

Who may be able to join

  • age 65 or above;
  • able to walk independently indoor for at least 20 metres without a walking aid.

Who cannot join

  • a total score of less than 24 on the MMSE-C (Chiu et al., 1994; Folstein et al., 1975);
  • the presence of any untreated cerebral vascular disease, Parkinson's disease, or any other major neurological deficit;
  • the presence of an unstable medical condition affecting safety while walking ;
  • a history of a major fall incident within the last year;
  • a static visual acuity poorer than 20/40 vision (assessed using the Tumbling E eye chart).

Trial locations and contacts

1 site in 1 country.

China1 site
  • The Hong Kong Polytechnic University

    Hong Kong

Other trials in China

About this study

Official title: The Effects of Attentional Focus Instructions on Real-time Conscious Movement Processing While Walking in a Challenging Environment for Older Adults at Risk of Falling in Hong Kong: Implications for Rehabilitation

This study aims to provide a novel scientific contribution through addressing critical knowledge gaps, examining the effects of attentional focus instructions on real-time (state) conscious movement processing propensity, gait parameters, and muscle efficiency in older adults in Hong Kong at risk of falling while walking in a challenging environment. The study results could update our scientific understanding of the mechanisms of conscious movement processing and the interventional effects of attentional focus instructions in older adults. It could ultimately enhance the methodology used for developing the most appropriate psychomotor gait re-education intervention in rehabilitation and provide clear guidelines on the exact attentional focus training that older adults require. Further, it could mitigate the effect of conscious movement processing and risk of falling in older adults.

Being tested
Walking trials
Keywords
Attentional focus instructions, Conscious movement processing, Walking, Muscle efficiency, Gait parameters
Medical subject headings
Mobility Limitation, Gait Disorders, Neurologic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Walking trialsOther

    All participants will complete a series of walking trials. They will first be requested to perform three practice walks followed by three walking trials on a 7.4m straight level-ground firm walkway (GW) and the other three walking trials on a 7.4m straight foam walkway (FW) in a randomised order. The dimension of the foam walkway in the FW will be 8m (length), 0.8m (width), and 0.3m (height). The starting and finishing lines of the FW will be positioned at 0.3m from each side of the FW's edges. Thus, the lengths of the FW and the GW will be identical (i.e., 7.4m). Participants will be asked to walk 7.4m and stop for each walking trial.

    After a 10-minute rest break, participants will perform nine walking trials on the GW and the other nine walking trials on the FW, including three repetitions of three different attentional focus instructions (external focus [EF], internal focus [IF], and no specific focus [NF]) in the GW and FW in a randomised order.

Study groups in NCT05411536
Study groupRoleWhat they receive
high reinvestor group (HRG)The participants were divided into two groups, the high reinvestor group (HRG) and the low reinvestor group (LRG), using the conventional median split of their scores on the MSRS-C (Chu \& Wong, 2019; Mak et al., 2020).
Receives: Other: Walking trials
low reinvestor group (LRG)The participants were divided into two groups, the high reinvestor group (HRG) and the low reinvestor group (LRG), using the conventional median split of their scores on the MSRS-C (Chu \& Wong, 2019; Mak et al., 2020).
Receives: Other: Walking trials

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Real-time (state) conscious movement processing propensity

    It will be measured by the Alpha2 EEG T3-Fz coherence.

    Measured: Day 0

  2. Gait speed

    It will be measured by the 3-D motion-capture system in the unit of meter per second (m/s).

    Measured: Day 0

  3. Body sway

    It will be measured by the 3-D motion-capture system in the unit of millimeter (mm).

    Measured: Day 0

  4. Stride length

    It will be measured by the 3-D motion-capture system in the unit of meter (m).

    Measured: Day 0

  5. Stride-to-stride variability

    It will be measured by the 3-D motion-capture system by the coefficients of variation (CV).

    Measured: Day 0

  6. Muscle efficiency

    It will be measured by the surface electromyography (EMG).

    Measured: Day 0

Secondary outcomes (4)
  1. Walking ability

    It will be measured by the Timed 'Up \& Go' tests.

    Measured: Day 0

  2. Balance ability

    It will be measured by the Berg Balance Scale. The minimum value of the scale is 0 and the maximum value is 56. Higher score represents better balance ability.

    Measured: Day 0

  3. Fear of falling

    It will be measured by the Chinese version of the Falls Efficacy Scale International. The minimum value of the scale is 16 and the maximum value is 64. Higher score represents higher fear of falling.

    Measured: Day 0

  4. Trait conscious movement processing propensity

    It will be measured by the Chinese version of the Movement-Specific Reinvestment Scale. The minimum value of the scale is 10 and the maximum value is 60. Higher score represents higher trait conscious movement processing propensity.

    Measured: Day 0

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jun 2022
  2. Study start15 Jul 2022
  3. Primary completion30 Jun 2024 (estimated)
  4. Study completion30 Jun 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
106 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05411536
Sponsor's protocol ID
15601021
Status last verified
Feb 2024
First submitted
1 Jun 2022
Last updated
29 Feb 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Mak TCT, Ng SSM, Leung MCY, Wong TWL. Stress-Induced Responses in Conscious Movement Processing and Walking Behaviour in Older Adults. Stress Health. 2025 Jun;41(3):e70065. doi: 10.1002/smi.70065.

    PubMed 40522681
  • Mak TCT, Ng SSM, Chan DCL, Wong TWL. The Influence of Attentional Focus on Gait Stability and Conscious Movement Processing During Challenging Walking Conditions in Older Adults. J Gerontol B Psychol Sci Soc Sci. 2025 May 8;80(6):gbaf059. doi: 10.1093/geronb/gbaf059.

    PubMed 40117215

Questions about this trial

What is this clinical trial studying?

An observational study of Fall Injury and Walking, Difficulty, run by The Hong Kong Polytechnic University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 29 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Real-time (state) conscious movement processing propensity (time frame: Day 0). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05411536, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in